A research-only label
The US agency that regulates drugs is called the Food and Drug Administration, or FDA.
Some sellers labelled cagrilintide products for research only. FDA letters said the sellers’ websites offered them as unapproved medicines for people.
FDA said the research labels did not change that finding. These letters were checked September 28, 2026.
- Those are FDA allegations about particular businesses, not court findings.
- Ask whether the offer is for an approved medicine or a place in a study, and ask for the record behind that answer.
A code presented as approval
The National Drug Code Directory identifies a product with a code called an NDC.
- An NDC number does not prove FDA approval. FDA guidance said this at the September 26, 2026 check.
- Ask to see the record showing approval of that specific product.
A pharmacy-made product called approved
Compounding means making a medicine to order.
Compounded medicines are not FDA-approved. FDA guidance stated this at the September 26, 2026 check.
Generic means an approved copy of a branded medicine.
- No generic semaglutide (Ozempic, Wegovy) had final US approval allowing it to be sold at the September 26, 2026 check.
- FDA guidance at that check said calling a compounded drug a generic version of an approved medicine was misleading.
A menu instead of a health assessment
Choosing a drug from a menu without a health assessment falls short of proper care. Medical-board guidance said this in May 2026.
- The guidance is from a group of bodies that oversee doctors: the Federation of State Medical Boards. It is not a nationwide law.
- The rules that can be enforced depend on your state.
- Ask your state medical board which rule applies to the offer.
- Ask who assesses the health question and how you can ask that person more questions.